Bank Of America Corp Magenta Therapeutics, Inc. Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.62 - $0.79 $189 - $240	-305 Reduced 1.08%	27,917 $21,000
Q1 2023 May 12, 2023	BUY	$0.41 - $0.86 $8,687 - $18,221	21,188 Added 301.22%	28,222 $22,000
Q4 2022 Feb 10, 2023	BUY	$0.36 - $1.59 $2,470 - $10,912	6,863 Added 4013.45%	7,034 $2,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $171 - $284	136 Added 388.57%	171 $0
Q2 2022 Aug 12, 2022	SELL	$0.97 - $3.08 $7,797 - $24,760	-8,039 Reduced 99.57%	35 $0
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $106,021 - $217,447	-41,577 Reduced 83.74%	8,074 $23,000
Q4 2021 Feb 08, 2022	BUY	$4.43 - $8.33 $48,818 - $91,796	11,020 Added 28.53%	49,651 $220,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $164,794 - $268,503	27,149 Added 236.45%	38,631 $281,000
Q2 2021 Sep 13, 2021	BUY	$9.76 - $14.15 $112,064 - $162,470	11,482 New	11,482 $113,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.